The long-term goal of this proposal is to understand the molecular basis for physiological effects elicited by epinephrine via alpha-adrenergic receptors of the pharmacological alpha-2-subtype. We will address this long-term goal by focusing on the manner in which sodium ion (Na+) influences alpha-2-receptor-agonist interactions and alpha-2-receptor-induced function.
The specific aims of the present proposal are to 1) purify the alpha-2-receptor to homogeneity, 2) evaluate whether the effects of Na+ on the purified alpha-2-receptor are conveyed via the betagamma heterodimer of the GTP-binding protein heterotrimer (Gi: alphabetagamma) which modulates alpha-2-receptor functions or, alternatively, via a Na+/H+ antiporter, 3) reconstitute the alpha-2-adrenergic receptor with the putative Na+-effector component in lipid vesicle preparations to test the conclusions drawn in #2 and 4) utilize permeabilized platelets to determine whether Gi represents the interface between the alpha-2-receptor and the Na+/H+ exchange mechanism and/or phospholipase A-2 activity postulated to be involved in epinephrine-provoked platelet secretion. Alpha-2-receptors are one of a number of hormone and neurotransmitter receptor populations which are linked to inhibition of adenylate cyclase activity. A number of lines of evidence suggest that the resultant decreases in cAMP levels are not sufficient to """"""""signal"""""""" a physiological effect, but that other important biochemical changes must also be evoked by these receptor populations. Receptors which can inhibit cAMP accumulation are all known to be modulated by Na+. Our studies, which focus on the basis for this role of Na+, should provide fundamental new insights into how alpha-2-adrenergic receptors elicit their physiological effects, in particular, and what are the alternate signaling mechanisms utilized by receptors linked to inhibition of adenylate cyclase activity, in general. Our model system for assessment of alpha-2-receptor-provoked function, i.e. epinephrine-induced platelet aggregation and secretion, will be of particular significance in understanding normal and pathological hemostasis, since platelet plug formation is necessary to prevent excessive blood loss but, when occurring inappropriately, forms thrombi that can precipitate strokes or myocardial infarction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL025182-11A1
Application #
3337981
Study Section
Toxicology Subcommittee 2 (TOX)
Project Start
1979-12-01
Project End
1995-11-30
Budget Start
1990-12-24
Budget End
1991-11-30
Support Year
11
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Lu, Roujian; Li, Yong; Zhang, Youwen et al. (2009) Epitope-tagged receptor knock-in mice reveal that differential desensitization of alpha2-adrenergic responses is because of ligand-selective internalization. J Biol Chem 284:13233-43
Wang, Qin; Lu, Roujian; Zhao, Jiali et al. (2006) Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 281:25948-55
Peng, Ning; Chambless, Brandon D; Oparil, Suzanne et al. (2003) Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus. Hypertension 41:571-5
Wilson, M H; Limbird, L E (2000) Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor. Biochemistry 39:693-700
Schramm, N L; Limbird, L E (1999) Stimulation of mitogen-activated protein kinase by G protein-coupled alpha(2)-adrenergic receptors does not require agonist-elicited endocytosis. J Biol Chem 274:24935-40
Edwards, S W; Limbird, L E (1999) Role for the third intracellular loop in cell surface stabilization of the alpha2A-adrenergic receptor. J Biol Chem 274:16331-6
Lakhlani, P P; MacMillan, L B; Guo, T Z et al. (1997) Substitution of a mutant alpha2a-adrenergic receptor via ""hit and run"" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc Natl Acad Sci U S A 94:9950-5
Lakhlani, P P; Lovinger, D M; Limbird, L E (1996) Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling. Mol Pharmacol 50:96-103
Ceresa, B P; Limbird, L E (1994) Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic recepto J Biol Chem 269:29557-64
Keefer, J R; Nunnari, J; Pang, I H et al. (1994) Introduction of purified alpha 2A-adrenergic receptors into uniformly oriented, unilamellar, phospholipid vesicles: productive coupling to G proteins but lack of receptor-dependent ion transport. Mol Pharmacol 45:1071-81

Showing the most recent 10 out of 32 publications